Breaking News Instant updates and real-time market news.

AMD

AMD

$20.29

-0.46 (-2.22%)

13:56
01/09/19
01/09
13:56
01/09/19
13:56

AMD sees third Gen Ryzen, EPYC 'Rome' coming in mid-2019

During her CES 2019 keynote presentation, AMD President and CEO Dr. Lisa Su announced "the world's first 7nm gaming graphics processing unit, AMD Radeon VII; detailed the world's fastest processor for ultrathin laptops, 2nd Gen AMD Ryzen Mobile processors; and provided the first public demonstration of the upcoming 7nm 3rd Gen AMD Ryzen desktop processor," the company stated in a press release following the presentation. The AMD Radeon VII graphics card is expected to be available beginning February 7, 2019. The third Gen Ryzen desktop processor is planned for introduction in mid-2019. The AMD EPYC "Rome" processor is on track to start shipping in mid-2019.

AMD AMD
$20.29

-0.46 (-2.22%)

01/04/19
01/04/19
UPGRADE
Target $60

Buy
BofA/Merrill prefers cloud and 5G exposure in semis, upgrades Intel to Buy
As previously reported, BofA Merrill Lynch analyst Vivek Arya upgraded Intel (INTC) to Buy from Neutral, stating that the stock provides attractive exposure to growth trends in cloud computing, AI, advanced autos and 5G. He forecasts total semiconductor industry sales to decelerate to down 3% year-over-year in 2019 and still expects enterprise, data center and parts of networking infrastructure to perform better than cyclical sectors such as industrial, automotive and smartphones, Arya tells investors. Risks, such as AMD (AMD) share loss, 7nm product delays, and tougher PC/data center comps, do exist, but now appear to be reflected in Intel shares, the analyst added. He raised his price target on Intel shares to $60 from $52.
12/27/18
RBCM
12/27/18
NO CHANGE
Target $200
RBCM
Outperform
Nvidia, AMD estimates lowered at RBC Capital on more cautious gaming view
RBC Capital analyst Mitch Steves lowered his price target on Nvidia (NVDA) to $200 from $230 and also lowered his FY19 revenue forecast on Advanced Micro Devices (AMD) to $7.29B from $7.41B. The analyst says the revisions reflect his observation of a reduction in average selling prices for GPUs of both companies in the secondary market, particularly for Nvidia's GTX 1070 gaming chip. Steves warns that the company may not be able to discern whether the lower prices come as a result of reduced demand in gaming or cryptocurrency related activity, but states that his expectations for Gaming sector are "conservative". The analyst also expects both Nvidia and AMD stocks to remain range bound until the air-pocket in gaming has passed over the near term. Longer term, Steves keeps his Outperform rating on Nvidia amid the sales mix shift toward Data Center revenues, which is seeing traction with the expected annualized growth. For AMD, the analyst also maintains an Outperform rating stating that its long-term investment story remains unchanged. In Q1, Steves sees AMD catalysts in the form a new server product with competitive performance and price relative to the current Intel (INTC) offerings.
12/21/18
DAIW
12/21/18
INITIATION
Target $26
DAIW
Buy
AMD initiated with a Buy at Daiwa
Daiwa initiated AMD with a Buy and $26 price target.
12/20/18
BOFA
12/20/18
NO CHANGE
Target $27
BOFA
Buy
BofA/Merrill sees prolonged weakness in GPUs, lowers AMD price target to $27
BofA Merrill Lynch analyst Vivek Arya said his recent checks suggests there will be prolonged weakness in GPUs over the next few quarters and he trimmed his Q4 and 1H19 sales and EPS estimates for AMD in response. He expects a recovery starting in Q3 in graphics and more backend weighted growth from AMD's next-gen EPYC server chip, "Rome," Arya tells investors. The analyst, who lowered his 2018 EPS estimate by 2c to 44c, which is below the Street at 46c, and lowered his 2019 EPS by 8c to be in-line with consensus at 62c, cut his price target on AMD shares to $27 from $30. Arya keeps a Buy rating on AMD.

TODAY'S FREE FLY STORIES

TS

Tenaris

$27.38

0.48 (1.78%)

16:32
02/20/19
02/20
16:32
02/20/19
16:32
Earnings
Tenaris reports Q4 EPS 38c, consensus 43c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    May

NDSN

Nordson

$138.81

-0.42 (-0.30%)

16:31
02/20/19
02/20
16:31
02/20/19
16:31
Earnings
Nordson reports Q1 adjusted EPS 92c, consensus $1.12 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 26

    Feb

SNPS

Synopsys

$102.98

1.08 (1.06%)

16:31
02/20/19
02/20
16:31
02/20/19
16:31
Earnings
Synopsys sees Q2 adjusted EPS $1.07-$1.12, consensus $1.05 »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 03

    Mar

  • 08

    Mar

  • 14

    Mar

  • 17

    Mar

  • 16

    Jul

  • 17

    Jul

  • 26

    Sep

  • 27

    Sep

OMCL

Omnicell

$84.04

1.04 (1.25%)

16:31
02/20/19
02/20
16:31
02/20/19
16:31
Conference/Events
Omnicell management to meet with Benchmark »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 30

    May

SAM

Boston Beer

$267.95

-0.97 (-0.36%)

16:30
02/20/19
02/20
16:30
02/20/19
16:30
Earnings
Boston Beer reports Q4 EPS $1.86, consensus $1.70 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

HCSG

Healthcare Services

$39.96

-0.37 (-0.92%)

16:30
02/20/19
02/20
16:30
02/20/19
16:30
Conference/Events
Healthcare Services management to meet with Benchmark »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

16:30
02/20/19
02/20
16:30
02/20/19
16:30
Options
Preliminary option volume of 17.7M today »

Preliminary option volume…

SNPS

Synopsys

$102.98

1.08 (1.06%)

16:29
02/20/19
02/20
16:29
02/20/19
16:29
Earnings
Synopsys reports Q1 EPS $1.08, consensus 97c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 03

    Mar

  • 08

    Mar

  • 14

    Mar

  • 17

    Mar

  • 16

    Jul

  • 17

    Jul

  • 26

    Sep

  • 27

    Sep

WK

Workiva

$44.27

0.48 (1.10%)

16:29
02/20/19
02/20
16:29
02/20/19
16:29
Earnings
Workiva sees FY19 adjusted EPS (39c)-(34c), consensus (30c) »

Sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

  • 25

    Feb

UFPI

Universal Forest

$32.68

-0.12 (-0.37%)

16:29
02/20/19
02/20
16:29
02/20/19
16:29
Earnings
Universal Forest reports Q4 EPS 50c, consensus 52c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

WRI

Weingarten Realty

$29.56

-0.27 (-0.91%)

16:29
02/20/19
02/20
16:29
02/20/19
16:29
Earnings
Weingarten Realty sees FY19 FFO $2.09-$2.17, consensus $2.23 »

Sees same-store NOIC up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

WK

Workiva

$44.27

0.48 (1.10%)

16:28
02/20/19
02/20
16:28
02/20/19
16:28
Earnings
Workiva sees Q1 adjusted EPS (5c)-(4c), consensus (6c) »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

  • 25

    Feb

CYH

Community Health

$4.07

0.09 (2.26%)

16:28
02/20/19
02/20
16:28
02/20/19
16:28
Earnings
Community Health reports Q4 adjusted EPS (42c), consensus (58c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

WRI

Weingarten Realty

$29.56

-0.27 (-0.91%)

16:28
02/20/19
02/20
16:28
02/20/19
16:28
Earnings
Weingarten Realty reports Q4 FFO 55c, consensus 57c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

WK

Workiva

$44.27

0.48 (1.10%)

16:28
02/20/19
02/20
16:28
02/20/19
16:28
Earnings
Workiva reports Q4 adjusted EPS 0c, consensus (10c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

  • 25

    Feb

GHDX

Genomic Health

$83.70

1.11 (1.34%)

16:28
02/20/19
02/20
16:28
02/20/19
16:28
Earnings
Genomic Health sees FY19 EPS $1.38-$1.54, consensus $1.25 »

Sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

RPT

Ramco-Gershenson

$13.33

-0.07 (-0.52%)

16:27
02/20/19
02/20
16:27
02/20/19
16:27
Earnings
Breaking Earnings news story on Ramco-Gershenson »

Ramco-Gershenson sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

RBBN

Ribbon Communications

$6.06

-0.08 (-1.30%)

16:27
02/20/19
02/20
16:27
02/20/19
16:27
Earnings
Ribbon Communications reports Q4 adjusted EPS 26c, consensus 25c »

Reports Q4 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

  • 06

    Mar

WPX

WPX Energy

$13.40

0.16 (1.21%)

16:26
02/20/19
02/20
16:26
02/20/19
16:26
Earnings
WPX Energy reports Q4 adjusted EPS 2c, consensus 6c »

Reports Q4 product…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

CAR

Avis Budget

$29.35

-0.23 (-0.78%)

16:26
02/20/19
02/20
16:26
02/20/19
16:26
Hot Stocks
Breaking Hot Stocks news story on Avis Budget »

Avis Budget higher by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 20

    Mar

  • 21

    Mar

GHDX

Genomic Health

$83.70

1.11 (1.34%)

16:26
02/20/19
02/20
16:26
02/20/19
16:26
Earnings
Genomic Health reports Q4 EPS 23c, consensus 30c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

CECO

Career Education

$13.93

0.05 (0.36%)

16:26
02/20/19
02/20
16:26
02/20/19
16:26
Earnings
Career Education sees 2019 adjusted EPS $1.11-$1.15, consensus $1.11 »

For CTU, new student…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 14

    Mar

RPT

Ramco-Gershenson

$13.33

-0.07 (-0.52%)

16:26
02/20/19
02/20
16:26
02/20/19
16:26
Earnings
Ramco-Gershenson reports Q4 FFO 31c, consensus 29c »

"2018 marked a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

CAR

Avis Budget

$29.35

-0.23 (-0.78%)

16:26
02/20/19
02/20
16:26
02/20/19
16:26
Earnings
Avis Budget sees FY19 EPS $3.35-$4.20, consensus $3.79 »

Sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 20

    Mar

  • 21

    Mar

ES

Eversource

$70.27

-0.14 (-0.20%)

16:25
02/20/19
02/20
16:25
02/20/19
16:25
Earnings
Eversource reports Q4 EPS 73c, consensus 76c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 04

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.